Hyku Biosciences
Expanding the boundaries of drug discovery
Burlington, United States · Founded 2023 · $56.0M raised
- Headquarters
- Burlington, Massachusetts
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- hykubiosciences.com
- Total Funding
- $56.0M
- Last Round
- $56.0M Extension RoundNov 2024
- Rounds
- 2
About
Hyku Biosciences is a biotechnology company pioneering precise covalent targeting of disease-causing proteins to develop novel small molecule therapeutics. The company's proprietary Hyku platform identifies compounds that covalently bind non-cysteine amino acids — including histidine, tyrosine, and lysine — enabling development of therapies that address selectivity, druggability, and resistance challenges across oncology and other disease areas. Hyku launched in September 2023 with $56 million in seed financing and is headquartered in Burlington, Massachusetts.
Summary
Hyku Biosciences is a Biotech company based in Burlington, United States, founded in 2023. It has raised $56.0M in total across 2 rounds, most recently a $56.0M Extension Round round in Nov 2024.
Funding History
Nov 2024
Sign up to see all 2 rounds
Seed through Extension Round — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hyku-biosciences"><img src="https://indexed.vc/api/badge/company/hyku-biosciences" alt="Hyku Biosciences on Indexed.vc" width="260" height="76" /></a>